Tuberculosis and Respiratory Diseases

  • 제84권1호
  • /
  • Pages.85-86
  • /
  • 2021
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

Importance of Public-Private Mix Collaboration in Tuberculosis Control: It Is Also Valuable in Patients with Multidrug-Resistant Tuberculosis

  • Kwon, Yong-Soo (Department of Internal Medicine, Chonnam National University Hospital)
  • 투고 : 2020.11.29
  • 심사 : 2020.12.03
  • 발행 : 2021.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. World Health Organization. Global tuberculosis report 2019 [Internet]. Geneva: World Health Organization; 2019 [cited 2020 Jul 31]. Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1.
  2. Keshavjee S, Farmer PE. Tuberculosis, drug resistance, and the history of modern medicine. N Engl J Med 2012;367:931-6. https://doi.org/10.1056/NEJMra1205429
  3. Jeon D. Medical management of drug-resistant tuberculosis. Tuberc Respir Dis 2015;78:168-74. https://doi.org/10.4046/trd.2015.78.3.168
  4. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea 2019 [Internet]. Cheongwon: Korea Centers for Disease Control and Prevention; 2020 [cited 2020 Nov 24]. Available from: http://tbzero.cdc.go.kr/tbzero/board/boardView.do.
  5. Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, et al. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008;178:1075-82. https://doi.org/10.1164/rccm.200801-132OC
  6. Go U, Park M, Kim UN, Lee S, Han S, Lee J, et al. Tuberculosis prevention and care in Korea: evolution of policy and practice. J Clin Tuberc Other Mycobact Dis 2018;11:28-36. https://doi.org/10.1016/j.jctube.2018.04.006
  7. Kang Y, Jo EJ, Eom JS, Kim MH, Lee K, Kim KU, et al. Treatment outcomes of patients with multidrug-resistant tuberculosis: comparison of pre- and post-public-private mix periods. Tuberc Respir Dis 2021;84.
  8. Ottmani SE, Zignol M, Bencheikh N, Laasri L, Chaouki N, Mahjour J. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis 2006;10:1367-72.
  9. Gler MT, Macalintal LE, Raymond L, Guilatco R, Quelapio MI, Tupasi TE. Multidrug-resistant tuberculosis among previously treated patients in the Philippines. Int J Tuberc Lung Dis 2011;15:652-6. https://doi.org/10.5588/ijtld.10.0400
  10. Kolappan C, Subramani R, Kumaraswami V, Santha T, Narayanan PR. Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. Int J Tuberc Lung Dis 2008;12:81-6.
  11. Jeon D. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update: applicability in South Korea. Tuberc Respir Dis 2017;80:336-43. https://doi.org/10.4046/trd.2017.0049